Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C9DC2F7D.svg?ark=w1%2F20260515%2FC9DC2F7D)](https://nobleid.org/work/w1/20260515/C9DC2F7D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors